The Impact of Telehealth on the Future Care-Delivery Landscape

Summary

Avalere experts explored the future role of telehealth and how organizations can help shape and take advantage of its increased utilization.

Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Access Recording

The COVID-19 pandemic has presented significant challenges to the care-delivery landscape. These issues have led to delays or gaps in care and undiagnosed and undermanaged conditions. Telehealth has rapidly expanded to help meet some of these challenges. While telehealth is not new, the recent environmental dynamics and state and federal facilitation of telehealth have led to extensive growth in how it is being used and are poised to reposition the value of telehealth in the care delivery landscape. As states begin to open up and elective care resumes, all stakeholders need to consider which, if any, of these new flexibilities should and will remain and what that will mean for the care-delivery system.

Key Topics

Current and future implications for manufacturers, payers, providers, patients, and other stakeholders
The new flexibilities that have the best chance to remain post-pandemic
Long-term impacts on care delivery and patients’ health
Historical barriers to adoption to be addressed
Engagement strategies to affect policy, coverage, or utilization of telehealth

Panelists

Moderator

Chad Brooker , Associate Principal, Policy

Chad provides strategic advice to health plan, life sciences, and advocacy organizations on the complex legislative and regulatory policy environments at both the state and federal levels.

Speaker

Josh Seidman

Josh Seidman advises clients on health delivery and payment innovation with a focus on using information technology to guide value-based care models.

Speaker

Danielle Showalter , Principal, Commercialization & Regulatory Strategy

Danielle Showalter advises clients on reimbursement, policy, and market access strategies for diagnostic, medical device, and pharmaceutical companies.

Guest Speaker

Nader Hawit , Senior Director, Product Execution, and General Manager, Prospective Advantage™, Inovalon

Nader Hawit holds the responsibility for end-to-end execution for Prospective Advantage™, from analytics and intervention strategy through intervention execution, data collection, and reporting.